Pharma and Biotech
Director/PDMR Dealings | 05-Nov-2024 | 14:25 | RNS |
Result of General Meeting | 04-Nov-2024 | 10:17 | RNS |
Publication of Prospectus & Notice of GM | 16-Oct-2024 | 13:37 | RNS |
£300,000 Fundraise | 20-Sep-2024 | 14:24 | RNS |
Half-year Report | 18-Jun-2024 | 07:00 | RNS |
Patent Update | 17-Jun-2024 | 07:00 | RNS |
Result of AGM | 19-Mar-2024 | 14:39 | RNS |
Subscription to raise £150,000 | 01-Mar-2024 | 07:00 | RNS |
Posting of Annual Report and Notice of AGM | 15-Jan-2024 | 11:30 | RNS |
Results for the period ended 30 September 2023 | 03-Jan-2024 | 07:00 | RNS |
NXP001 Update | 18-Dec-2023 | 07:00 | RNS |
Notice of Allowance of NXP002 Patent in Japan | 23-Oct-2023 | 07:00 | RNS |
NXP001 Update | 18-Sep-2023 | 07:00 | RNS |
Result of Annual General Meeting | 24-Aug-2023 | 13:22 | RNS |
Notice of AGM | 31-Jul-2023 | 14:00 | RNS |
Currency | UK Pounds |
Share Price | 0.048p |
Change Today | 0.003p |
% Change | -5.00 % |
52 Week High | 0.40p |
52 Week Low | 0.046p |
Volume | 13,310,496 |
Shares Issued | 1,419.31m |
Market Cap | £0.67m |
Beta | 0.07 |
RiskGrade | 322 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:05 | 223,350 @ 0.049p |
11:00 | 1,076,902 @ 0.047p |
09:51 | 2,010,244 @ 0.049p |
09:20 | 10,000,000 @ 0.046p |
You are here: research